The road to Aduhelm: What one ex-FDA adviser called ‘probably the worst drug approval decision in recent US history’ for an Alzheimer’s treatment | CNN Politics

- Source: CNN " data-fave-thumbnails="{"big": { "uri": "https://media.cnn.com/api/v1/images/stellar/prod/210927071933-toobin-new-day-9-27-2021.jpg?q=x_2,y_0,h_1078,w_1915,c_crop/h_540,w_960" }, "small": { "uri": "https://media.cnn.com/api/v1/images/stellar/prod/210927071933-toobin-new-day-9-27-2021.jpg?q=x_2,y_0,h_1078,w_1915,c_crop/h_540,w_960" } }" data-vr-video="false" data-show-html=" New Day

[mshkh]

"the agency chose to use the accelerated approval pathway to allow earlier access to patients" "reducing amyloid has not meant that anyone is actually getting better." "User fees now pay for roughly 45% of the FDA's budget." さすがCNNという記事